Table 1 Comparison of clinical characteristics between patients with and without elevated CK-MB
Characteristic | Overall (n = 1131) | log(CK-MB) ≤ 4.70(n = 920) | log(CK-MB) > 4.70 (n = 211) | p-value |
|---|---|---|---|---|
Demographic characteristics | ||||
Age (years) | 60.87 ± 12.05 | 60.90 ± 12.00 | 60.71 ± 12.28 | 0.834 |
Male gender | 932 (82.40%) | 761 (82.72%) | 171 (81.04%) | 0.634 |
Weight (kg) | 65.74 ± 10.84 | 65.71 ± 10.96 | 65.89 ± 10.31 | 0.842 |
BMI (kg/m2) | 23.91 ± 3.21 | 23.91 ± 3.24 | 23.93 ± 3.06 | 0.958 |
Medical history and clinical condition | ||||
CI-AKI | 62 (5.48%) | 37 (4.02%) | 25 (11.85%) | < 0.001 |
Smoking history | 542 (47.92%) | 424 (46.09%) | 118 (55.92%) | 0.012 |
DM | 295 (26.08%) | 243 (26.41%) | 52 (24.64%) | 0.659 |
Hypertension | 562 (49.69%) | 471 (51.20%) | 91 (43.13%) | 0.042 |
Hyperlipidemia | 139 (12.29%) | 106 (11.52%) | 33 (15.64%) | 0.127 |
CKD | 607 (53.67%) | 496 (53.91%) | 111 (52.61%) | 0.790 |
CHF | 460 (40.67%) | 368 (40.00%) | 92 (43.60%) | 0.377 |
Anterior infarction | 399 (35.28%) | 291 (31.63%) | 108 (51.18%) | < 0.001 |
Hypotension | 86 (7.60%) | 59 (6.41%) | 27 (12.80%) | 0.003 |
Anemia | 321 (28.38%) | 275 (29.89%) | 46 (21.80%) | 0.023 |
IABP | 42 (3.71%) | 28 (3.04%) | 14 (6.64%) | 0.022 |
LVEF (%) | 55.17 ± 11.34 | 55.91 ± 11.37 | 52.02 ± 10.69 | < 0.001 |
Procedure | ||||
Emergent PCI | 976 (86.30%) | 782 (85.00%) | 194 (91.94%) | 0.011 |
Laboratory examination | ||||
GLU(mmol/L) | 8.16 ± 3.89 | 8.03 ± 3.88 | 8.71 ± 3.91 | 0.022 |
Hb(g/L) | 128.05 ± 20.46 | 128.73 ± 20.21 | 125.05 ± 21.34 | 0.020 |
hct | 40.62 ± 5.87 | 40.39 ± 5.89 | 41.64 ± 5.68 | 0.006 |
Scr(mg/dl) | 95.37 ± 40.66 | 96.20 ± 42.43 | 91.72 ± 31.62 | 0.148 |
CCR(ng/ml) | 73.70 ± 28.88 | 73.36 ± 28.86 | 75.18 ± 28.98 | 0.410 |
eGFR(ml/min/1.73mm2) | 80.98 ± 26.73 | 80.69 ± 26.89 | 82.26 ± 26.04 | 0.441 |
BUN(mmol/L) | 5.00 [3.90, 6.50] | 4.91 [3.90, 6.48] | 5.20 [4.03, 6.58] | 0.143 |
HDL-C(mmol/L) | 1.00 ± 0.28 | 0.98 ± 0.27 | 1.08 ± 0.33 | < 0.001 |
ALB(g/L) | 36.10 ± 5.15 | 36.07 ± 5.12 | 36.23 ± 5.31 | 0.712 |
Treatment during hospitalization | ||||
ACEI/ARB | 145 (12.82%) | 133 (14.46%) | 12 (5.69%) | 0.001 |
Beta-blockers | 611 (54.02%) | 532 (57.83%) | 79 (37.44%) | < 0.001 |
CCB | 89 (7.87%) | 84 (9.13%) | 5 (2.37%) | 0.002 |
Statins | 912 (80.64%) | 764 (83.04%) | 148 (70.14%) | < 0.001 |
Hypoglycemic drugs | 125 (11.05%) | 115 (12.50%) | 10 (4.74%) | 0.002 |
Diuretic | 261 (23.08%) | 201 (21.85%) | 60 (28.44%) | 0.050 |
Contrast dose(ml) | 113.80 ± 50.15 | 112.14 ± 50.05 | 121.02 ± 50.08 | 0.021 |